Lumexa Imaging Holdings, Inc. Common Stock (LMRI) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of Lumexa Imaging Holdings, Inc. Common Stock and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Lumexa Imaging Holdings, Inc. Common Stock logo
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$1.02B
$10.60HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PROCEPT BioRobotics Corporation logo
PRCT
PROCEPT BioRobotics Corporation
$984M
$17.28HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — LMRI vs PRCT

growth of $100 · dividends reinvested · last 1y
LMRI -41.8% (-41.8%/yr)PRCT -50.1% (-50.1%/yr)LMRI compounded faster over this window
406080100Start $1002026$58$50
LMRI PRCT

LMRI vs PRCT: by the numbers

  • •LMRI is the larger company ($1.02B vs $984M market cap).
  • •Both run net losses; LMRI's is the smaller (-2.66% vs -32.54% net margin).

Metrics side by side

Valuation

MetricLMRIPRCT
Forward P/E16.51N/A
P/S ratio0.982.92
P/B ratio1.662.89
EV / EBITDA27.91N/A
FCF yield3.13%N/A

Profitability

MetricLMRIPRCT
Gross margin11.80%63.74%
Operating margin1.38%-33.86%
Net margin-2.66%-32.54%
ROE-4.51%-32.27%
ROIC0.86%-27.51%

Growth (annualized)

MetricLMRIPRCT
Revenue CAGR (5Y)N/A74.27%
Total return CAGR (5Y)N/A-14.36%

Go deeper

Full LMRI analysisFull PRCT analysisInteractive comparison tool

Dig into the metrics

Lumexa Imaging Holdings, Inc. Common Stock ROEPROCEPT BioRobotics ROELumexa Imaging Holdings, Inc. Common Stock operating marginPROCEPT BioRobotics operating marginLumexa Imaging Holdings, Inc. Common Stock revenue growthPROCEPT BioRobotics revenue growthLumexa Imaging Holdings, Inc. Common Stock free cash flowPROCEPT BioRobotics free cash flow

Lumexa Imaging Holdings, Inc. Common Stock & PROCEPT BioRobotics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.